文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

降钙素原对重症昏迷患者早期吸入性肺炎的诊断准确性:一项前瞻性研究

Diagnostic Accuracy of Procalcitonin for Early Aspiration Pneumonia in Critically Ill Patients with Coma: A Prospective Study.
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论在院外昏迷后需机械通气的ICU患者中,降钙素原、C反应蛋白和白细胞计数对吸入性肺炎的诊断性能均较差,48小时内降钙素原测定无助于诊断吸入性肺炎。

这项前瞻性观察性2年队列研究在内外科ICU纳入103例院外昏迷后需机械通气的患者,45例(44%)发生吸入性肺炎。在入组时及入组后6、12、24、48、96、120小时测定降钙素原、C反应蛋白和白细胞计数,以下呼吸道微生物学检查为参考标准诊断吸入性肺炎。三种生物标志物的ROC曲线下面积均较差,诊断吸入性肺炎的最佳ROC-AUC为C反应蛋白在24小时[0.73(95%CI 0.61-0.84)]和降钙素原在48小时[0.73(95%CI 0.61-0.84)]。降钙素原动力学变化最快,但入ICU后48小时内降钙素原测定无助于诊断吸入性肺炎。

要点

  • 在103例院外昏迷后需机械通气的ICU患者中,45例(44%)发生吸入性肺炎,三种生物标志物诊断性能均较差。
  • 诊断吸入性肺炎的最佳ROC-AUC为C反应蛋白在24小时[0.73(95%CI 0.61-0.84)]和降钙素原在48小时[0.73(95%CI 0.61-0.84)]。
  • 降钙素原在24小时的阳性似然比最佳为3.5,C反应蛋白和白细胞计数在24小时的阴性似然比均为0.4。
  • 降钙素原从入组时到120小时在吸入性肺炎患者中较无吸入性肺炎患者显著升高,且在三种标志物中变化最早。
  • 入ICU后48小时内降钙素原测定无助于诊断吸入性肺炎。

适用人群与场景

  • 院外昏迷后需机械通气的ICU患者,纳入103例。

研究设计与关键结果

  • 前瞻性观察性2年队列研究,在内外科ICU纳入103例院外昏迷后需机械通气的患者,45例(44%)发生吸入性肺炎。
  • 在入组时(H0)及入组后6小时(H)、12小时(H12)、24小时(H24)、48小时(H48)、96小时(H96)、120小时(H120)测定降钙素原、C反应蛋白和白细胞计数。
  • 以下呼吸道微生物学检查作为诊断吸入性肺炎的参考标准。
  • 降钙素原从H0到H120在吸入性肺炎患者中较无吸入性肺炎患者显著升高,且在三种标志物中变化最早。
  • 三种生物标志物的ROC曲线下面积均较差;诊断吸入性肺炎的最佳ROC-AUC为C反应蛋白在H24[0.73(95%CI 0.61-0.84)]和降钙素原在H48[0.73(95%CI 0.61-0.84)]。
  • 阳性似然比最佳为降钙素原在H24(3.5),阴性似然比最佳为C反应蛋白和白细胞计数在H24(分别为0.4和0.4)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,入ICU后48小时内降钙素原测定无助于诊断ICU昏迷患者的吸入性肺炎。
  • 三种生物标志物对排除吸入性肺炎的诊断性能均较差。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early diagnostic orientation for differentiating pneumonia from pneumonitis at the early stage after aspiration would be valuable to avoid unnecessary antibiotic therapy. We assessed the accuracy of procalcitonin (PCT) in diagnosing aspiration pneumonia (AP) in intensive care unit (ICU) patients requiring mechanical ventilation after out-of-hospital coma.

METHODS: Prospective observational 2-year cohort study in a medical-surgical ICU. PCT, C-reactive protein (CRP) and white blood cell count (WBC) were measured at admission (H0) and 6 h (H), H12, H24, H48, H96, and H120 after inclusion. Lower respiratory tract microbiological investigations performed routinely in patients with aspiration syndrome were the reference standard for diagnosing AP. Performance of PCT, CRP, and WBC up to H48 in diagnosing AP was compared based on the areas under the ROC curves (AUC) and likelihood ratios (LR+ and LR-) computed for the best cutoff values.

RESULTS: Of 103 patients with coma, 45 (44%) had AP. Repeated PCT assays demonstrated a significant increase in patients with AP versus without AP from H0 to H120. Among the three biomarkers, PCT showed the earliest change. ROC-AUC values were poor for all three biomarkers. Best ROC-AUC values for diagnosing AP were for CRP at H24 [0.73 (95%CI 0.61-0.84)] and PCT at H48 [0.73 (95%CI 0.61-0.84)]. LR+ was best for PCT at H24 (3.5) and LR- for CRP and WBC at H24 (0.4 and 0.4, respectively).

CONCLUSIONS: Early and repeated assays of PCT, CRP, and WBC demonstrated significant increases in all three biomarkers in patients with versus without AP. All three biomarkers had poor diagnostic performance for ruling out AP. Whereas PCT had the fastest kinetics, PCT assays within 48 h after ICU admission do not help to diagnose AP in ICU patients with coma.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Legriel S, Grigoresco B, Martel P, et al. Diagnostic Accuracy of Procalcitonin for Early Aspiration Pneumonia in Critically Ill Patients with Coma: A Prospective Study. Neurocrit Care. 2019. PMID: 30267280. doi:10.1007/s12028-018-0623-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。